about
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsAKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosisTyrosine phosphorylation controls PCNA function through protein stabilityThe LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancerRegulation of the PI3K pathway through a p85α monomer-homodimer equilibriumA general approach for characterizing glycosylation sites of glycoproteins.Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines.Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.Phosphopeptide enrichment by covalent chromatography after derivatization of protein digests immobilized on reversed-phase supportsA circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer.Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analoguesEvaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.An artifact in LC-MS/MS measurement of glutamine and glutamic acid: in-source cyclization to pyroglutamic acid.N-terminal protein characterization by mass spectrometry using combined microscale liquid and solid-phase derivatizationTargeted metabolomic analysis of amino acid response to L-asparaginase in adherent cellsA role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response.Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.NudC deacetylation regulates mitotic progression.N-terminal protein characterization by mass spectrometry after cyanogen bromide cleavage using combined microscale liquid- and solid-phase derivatization.Phosphopeptide Enrichment by Covalent Chromatography After Solid Phase Derivatization of Protein Digests on Reversed Phase Supports.PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesisSecreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activationStimulation of lung innate immunity protects against lethal pneumococcal pneumonia in miceA splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formationCaspase-10-mediated heat shock protein 90 beta cleavage promotes UVB irradiation-induced cell apoptosisFAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PESTImmunologic glycosphingolipidomics and NKT cell development in mouse thymus.EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.Molecular characterization of exosome-like vesicles from breast cancer cells.C-terminal protein characterization by mass spectrometry: isolation of C-terminal fragments from cyanogen bromide-cleaved protein.PKM2 regulates chromosome segregation and mitosis progression of tumor cells.A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors.Benchtop isolation and characterization of functional exosomes by sequential filtration.lncRNA directs cooperative epigenetic regulation downstream of chemokine signalsTumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.Genome-wide identification and differential analysis of translational initiation.A method for the isolation of blocked N-terminal peptides.
P50
Q24305218-487771CC-624E-4EFC-84AC-BCCE94D95E58Q24314880-E82F6564-11EA-45DB-AFC2-FB40656A3E47Q24317732-81FFFE0C-5330-4C54-A5FE-8A20EAB0ABF2Q28118941-D725AF92-8218-4E08-836A-9770BFB19902Q30009133-1F2EFFD6-3C99-431E-878E-380EF25E97BFQ30359395-D07003D6-BF7B-422E-8137-65B0906A3E4AQ30665370-4AC58233-1CBA-429E-B566-36E227CA9D67Q31083124-90C1F9AB-D6F2-4DF7-948F-12D4CFEBEEDAQ31136391-7EF3D237-8936-421C-B458-0CFFF415D11FQ33206732-57AD5C0D-E4C8-4CF1-8FC6-A025CFD5FBF0Q33215791-01BB4B91-9EF2-4AE2-9056-5F1D6B5890BEQ33615627-EA1115E2-6D73-4557-947B-AE8EA63A9DDFQ33688307-6B505930-916F-461F-9E0E-59C88E2EB61CQ33777165-C2424881-93C8-479E-BB71-14F33EE59F09Q34059971-B977036F-89C6-42E3-A6EB-D095AD1D3E1DQ34091338-C5368807-0FB0-4EB5-BBE2-A5AE91FEF825Q34433751-61589B18-E7AF-488B-866A-02B96CBCE199Q34572680-EA0E1910-8403-4CEA-BDDF-EFBA1FBCD1A8Q34654908-7B8B41EE-BF4C-47CE-91FB-A9DD5C6A8F59Q34998873-C7AB46DF-5746-420C-A179-D7B8F99B851FQ35136475-B10E7A01-7B99-422E-B888-5736636D8F10Q35846354-60406B79-8AB8-44C5-8C23-642A8B86DAF7Q36199783-99F0D7BF-F7C6-412B-AC18-99FD35E75E6DQ36672321-76A170E8-CD85-4D33-800A-7F6029C80974Q36718650-2E400FA1-E9D7-4B00-BEA1-39E754624E46Q36955860-D12B6643-5AA4-4426-B80E-588726157C42Q37233416-369F689C-659C-42A7-AB31-60B8490A069BQ37273345-BE584FAF-2C9C-4733-9816-7A076399E50BQ37287214-91AB1C87-313C-44E7-880E-C64E47470082Q37445118-F57CA468-4710-4D92-ABD5-C7D7F7067F70Q37607048-BCD347EB-33CE-4958-9E88-15F71A227B98Q37616912-03A3B618-5B34-478A-829E-3473F5C1B77FQ37638990-8AFB6F10-1F98-48A0-B3EC-055683507F36Q37679659-4C275882-FFFF-485C-B12B-A4E125345101Q38715635-CDB0B583-3EB3-4157-BB41-069E0B1D4AFFQ38933810-D5D74637-5D45-4C3E-B032-D65CA7D296F6Q38938483-A82E1173-F139-4ACD-BB36-46115D313C11Q40613625-BC08E7EE-2B9D-4B92-818C-94EAEA97D376Q47115752-35AC1587-EEB4-4C0C-A14C-7D157013EE2FQ51091529-BE68C08E-5CE9-4A18-80A3-428D7B89545C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David H Hawke
@ast
David H Hawke
@en
David H Hawke
@es
David H Hawke
@nl
David H Hawke
@sl
type
label
David H Hawke
@ast
David H Hawke
@en
David H Hawke
@es
David H Hawke
@nl
David H Hawke
@sl
prefLabel
David H Hawke
@ast
David H Hawke
@en
David H Hawke
@es
David H Hawke
@nl
David H Hawke
@sl
P106
P21
P31
P496
0000-0002-6102-7843